Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Regression of High-Risk Plaque with Lifestyle Changes

Diet and lifestyle intervention in addition to optimal medical therapy can slow down plaque building and even reduce plaque volume compared against optimal medical treatment (OTM) alone.

Regresión de placas de alto riesgo con cambios del estilo vida

Diet and lifestyle intervention are amongst the most important strategies to manage coronary artery disease. However, its direct impact on atherosclerosis remains unclear. 

Atherosclerosis plaque building is associated with the risk of rupture with cardiovascular consequences regardless stenosis degree. 

The present study recently published in J Am Coll Cardiol Img included 92 patients with non-obstructive coronary lesions by CT scan. 

Patients were randomized 1:1 to an intervention group (systematic followup with nutritionist and lifestyle changes + OTM) vs. A control group (OTM alone). 


Read also: ACC 2019 | The New ACC/AHA Guidelines on Primary Prevention Focus on Life Style, Diet and Socioeconomic Factors.


In all patients, CT was repeated after 66.9 ± 13.7 weeks. Primary end point was atheroma volume change and plaque composition. 

Coronary plaque components were classified based on Hounsfield units into dense calcium (>351 units), fibrous plaque (151 to 350 units) and fibrofatty plaque combined with necrotic core (-30 to 150 units).

Atheroma volume increased in the control branch (changed from 1.1 ± 3.4%; p=0.033) while remaining stable in the intervention group (change from 1% ± 4.2%. p=0.127).


Read also: The Crucial Significance of Lifestyle Changes.


A significant reduction in soft plaque was seen in both branches, though it was higher in the intervention group, where it reached mean 51.3 mm3.

Conclusion

Diet and lifestyle intervention together with OMT can slow down atherosclerosis progression and reduce non-calcified plaque volume compared against OMT alone. 

Original Title: High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonbstructive Coronary Disease. A Randomized Study.

Reference: Jan Henzel et al. J Am Coll Cardiol Img 2020, article in press. https://doi.org/10.1016/j.jcmg.2020.10.019.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | P2Y12 Inhibitor Monotherapy After Complex PCI in ACS: Results From the NEO-MINDSET COMPLEX Subanalysis

This is a summary of the NEO-MINDSET COMPLEX subanalysis, presented by Dr. Guy Prado at EuroPCR 2026, which evaluated P2Y12 inhibitor monotherapy versus dual...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...